Likewise, the haplotype *4, which contains variant rs689466, was associated with shorter disease-free survival among obese patients (HR<sub>adj</sub> = 3.3; 95% CI = 1.8-6.0), either in luminal (HR<sub>adj</sub> = 3.5; 95% CI = 1.6-7.3) or HER2-like and triple-negative (HR<sub>adj</sub> = 3.1; 95% CI = 1.1-8.9) tumors.